Chemoscale™ is a non-invasive test that analyses tumour cells to assess how a chemotherapy drug may work or may show resistance, guiding the selection of the most effective treatments. Chemoscale™ is an analysis of tumour cells to provide drug efficacy and resistance guidance for cancer therapy. With Chemoscale™ analysis, we aim to personalise cancer treatment by minimising the risks of therapy failure for the patient-saving money, reducing 'trial and error', and most importantly, decreasing the toxic effects of chemotherapy drugs by intensifying the attack on the cancer cells and not the patient.
Chemoscale™ isolates Circulating Tumour Associated Cells (C-TACs) from peripheral blood or tissue samples and analyses them in the laboratory to measure cell death when exposed to different chemotherapy drugs.
Chemoscale helps customise chemotherapy by testing drugs on tumour cells or C-TACs from a tissue or blood sample, identifying drug sensitivity and resistance to help select the most effective treatment, minimising trial and error.
